FDA Drug Application (022013) for OLUX E by DELCOR ASSET

Back to FDA Applications sponsored by DELCOR ASSET

Application Number022013
Product Number001
FormAEROSOL, FOAM;TOPICAL
Dosage0.05%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB2 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOLUX E
Active IngredientCLOBETASOL PROPIONATE

Active IngredientCount
List of drugs with Active Ingredient CLOBETASOL PROPIONATE10


Back to FDA Applications sponsored by DELCOR ASSET